Skip to content

Clinical trials

Terminated Purpura, Thrombocytopenic, Idiopathic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Terminated Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20103
20112
20121
20131
20151
20171
20181
20202
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Biopharma SRL3
Pfizer2
Shionogi2
Weill Medical College of Cornell University2
Boehringer Ingelheim1
Carelon Research1
Eisai Inc.1
Genzyme, a Sanofi Company1
Gilead Sciences1
Momenta Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic20
Thrombocytopenia4
Blood Platelet Disorders2
Hematologic Diseases2
Purpura, Thrombotic Thrombocytopenic2
Anemia, Hemolytic, Autoimmune1
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.